Multiple panel of biomarkers for TIA/stroke evaluation.
Dambinova
Svetlana A
SA
Khounteev
Guerman A
GA
Skoromets
Alexandr A
AA
D000328:Adult; D017153:Antibodies, Anticardiolipin / Q000097:blood; D017152:Antibodies, Antiphospholipid / Q000009:adverse effects / Q000097:blood; D001323:Autoantibodies / Q000097:blood; D015415:Biomarkers / Q000097:blood; D003937:Diagnosis, Differential; D018450:Disease Progression; D005260:Female; D018698:Glutamic Acid / Q000097:blood; D005998:Glycine / Q000008:administration & dosage; D006710:Homocysteine / Q000097:blood; D006801:Humans; D006973:Hypertension / Q000097:blood; D002546:Ischemic Attack, Transient / Q000097:blood / Q000175:diagnosis*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000175:diagnosis; D018696:Neuroprotective Agents / Q000008:administration & dosage; D011237:Predictive Value of Tests; D016194:Receptors, N-Methyl-D-Aspartate / Q000276:immunology; D020521:Stroke / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy; D014057:Tomography, X-Ray Computed
D017153:Antibodies, Anticardiolipin; D017152:Antibodies, Antiphospholipid; D001323:Autoantibodies; D015415:Biomarkers; C120997:NR2A NMDA receptor; D018696:Neuroprotective Agents; D016194:Receptors, N-Methyl-D-Aspartate; D006710:Homocysteine; D018698:Glutamic Acid; D005998:Glycine